Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 3/2014

01-03-2014 | Original Paper

Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI

Authors: Kalie Y. Kebed, Raed I. Al Adham, Kalkidan Bishu, J. Wells Askew, Kyle W. Klarich, Jae K. Oh, Paul R. Julsrud, Thomas A. Foley, James F. Glockner, Rick A. Nishimura, Steve R. Ommen, Nandan S. Anavekar

Published in: The International Journal of Cardiovascular Imaging | Issue 3/2014

Login to get access

Abstract

The presence of apical pouches in hypertrophic cardiomyopathy (HCM) may portend poor prognosis. We sought to study if the use cardiac magnetic resonance imaging (CMR) improves the detection of apical pouches in HCM compared to echocardiography. A retrospective review was performed of all consecutive HCM patients with an apical pouch identified by CMR at Mayo Clinic from May 2004 to Sept 2011. Clinical data was abstracted and CMR and echocardiographic images were analyzed. There were 56 consecutive HCM patients with an apical pouch identified by CMR. The predominant morphological type was apical in 41 (73.2 %), followed by sigmoid in 6 (10.7 %), reversed curve in 6 (10.7 %) and neutral in 3 (5.4 %). Obstructive physiology or systolic anterior motion of the mitral valve leaflet was evident in 23 (41.1 %). Late gadolinium enhancement was present in 47 (87.0 %) patients. Apical pouches were detected in only 18 (32.1 %) patients on echocardiography. Even when intravenous contrast was used (29/56 patients), in 16/29 (55.2 %) pouches were missed on echocardiography. Pouch length and neck dimensions in systole and diastole, measured on CMR, were larger among those patients in whom pouches were detected on echocardiography suggesting only larger pouches can be identified on echocardiography. In the largest CMR series to date of apical pouches in HCM, we show that while apical pouches are most commonly seen in apical HCM, they can be found in other phenotypic variants. CMR is better suited for the evaluation of apical pouches compared to echocardiography even with the use of intravenous contrast. CMR is likely a better tool for evaluating the cardiac apical structures including apical pouches when clinically indicated.
Literature
1.
go back to reference Klues HG, Schiffers A, Maron BJ (1995) Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26(7):1699–1708PubMedCrossRef Klues HG, Schiffers A, Maron BJ (1995) Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26(7):1699–1708PubMedCrossRef
2.
go back to reference Binder J et al (2006) Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clinic Proc 81(4):459–467CrossRef Binder J et al (2006) Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clinic Proc 81(4):459–467CrossRef
3.
go back to reference Maron MS et al (2008) Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 118(15):1541–1549PubMedCrossRef Maron MS et al (2008) Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 118(15):1541–1549PubMedCrossRef
4.
go back to reference Ando H et al (1990) Apical segmental dysfunction in hypertrophic cardiomyopathy: subgroup with unique clinical features. J Am Coll Cardiol 16(7):1579–1588PubMedCrossRef Ando H et al (1990) Apical segmental dysfunction in hypertrophic cardiomyopathy: subgroup with unique clinical features. J Am Coll Cardiol 16(7):1579–1588PubMedCrossRef
5.
go back to reference Wigle ED, Rakowski H (1992) Hypertrophic cardiomyopathy: when do you diagnose midventricular obstruction versus apical cavity obliteration with a small nonobliterated area at the apex of the left ventricle? J Am Coll Cardiol 19(3):525–526PubMedCrossRef Wigle ED, Rakowski H (1992) Hypertrophic cardiomyopathy: when do you diagnose midventricular obstruction versus apical cavity obliteration with a small nonobliterated area at the apex of the left ventricle? J Am Coll Cardiol 19(3):525–526PubMedCrossRef
6.
go back to reference Nakamura T et al (1992) Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol 19(3):516–524PubMedCrossRef Nakamura T et al (1992) Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol 19(3):516–524PubMedCrossRef
7.
go back to reference Fighali S et al (1987) Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 9(2):288–294PubMedCrossRef Fighali S et al (1987) Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 9(2):288–294PubMedCrossRef
8.
go back to reference Matsubara K et al (2003) Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 42(2):288–295PubMedCrossRef Matsubara K et al (2003) Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 42(2):288–295PubMedCrossRef
9.
go back to reference Sanghvi NK, Tracy CM (2007) Sustained ventricular tachycardia in apical hypertrophic cardiomyopathy, midcavitary obstruction, and apical aneurysm. Pacing Clin Electrophysiol PACE 30(6):799–803CrossRef Sanghvi NK, Tracy CM (2007) Sustained ventricular tachycardia in apical hypertrophic cardiomyopathy, midcavitary obstruction, and apical aneurysm. Pacing Clin Electrophysiol PACE 30(6):799–803CrossRef
10.
go back to reference Tse HF, Ho HH (2003) Sudden cardiac death caused by hypertrophic cardiomyopathy associated with midventricular obstruction and apical aneurysm. Heart 89(2):178PubMedCentralPubMedCrossRef Tse HF, Ho HH (2003) Sudden cardiac death caused by hypertrophic cardiomyopathy associated with midventricular obstruction and apical aneurysm. Heart 89(2):178PubMedCentralPubMedCrossRef
11.
go back to reference Lazaros G et al (2007) Apical hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm. Int J Cardiol 114(2):E45–E47PubMedCrossRef Lazaros G et al (2007) Apical hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm. Int J Cardiol 114(2):E45–E47PubMedCrossRef
12.
go back to reference Gersh BJ et al (2011) ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124(24):2761–2796PubMedCrossRef Gersh BJ et al (2011) ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124(24):2761–2796PubMedCrossRef
13.
go back to reference Binder J et al (2011) Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching. J Am Soc Echocardiogr 24(7):775–781PubMedCrossRef Binder J et al (2011) Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching. J Am Soc Echocardiogr 24(7):775–781PubMedCrossRef
14.
go back to reference Moon JC et al (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90(6):645–649PubMedCentralPubMedCrossRef Moon JC et al (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90(6):645–649PubMedCentralPubMedCrossRef
15.
go back to reference Rickers C et al (2005) Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112(6):855–861PubMedCrossRef Rickers C et al (2005) Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112(6):855–861PubMedCrossRef
16.
go back to reference Maron MS, Lesser JR, Maron BJ (2010) Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance. Am J Cardiol 105(12):1842–1843PubMedCrossRef Maron MS, Lesser JR, Maron BJ (2010) Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance. Am J Cardiol 105(12):1842–1843PubMedCrossRef
17.
go back to reference Kim KH et al (2012) Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with “pure” apical hypertrophic cardiomyopathy. J cardiovasc Magn Reson 14:52PubMedCentralPubMedCrossRef Kim KH et al (2012) Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with “pure” apical hypertrophic cardiomyopathy. J cardiovasc Magn Reson 14:52PubMedCentralPubMedCrossRef
18.
go back to reference Fattori R et al (2010) Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. Am J Cardiol 105(11):1592–1596PubMedCrossRef Fattori R et al (2010) Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. Am J Cardiol 105(11):1592–1596PubMedCrossRef
19.
go back to reference McKenna W et al (1981) Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 47(3):532–538PubMedCrossRef McKenna W et al (1981) Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 47(3):532–538PubMedCrossRef
20.
go back to reference Elliott P et al (2006) Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy. Eur Heart J 27(24):3073 author reply 3073-4PubMedCrossRef Elliott P et al (2006) Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy. Eur Heart J 27(24):3073 author reply 3073-4PubMedCrossRef
Metadata
Title
Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI
Authors
Kalie Y. Kebed
Raed I. Al Adham
Kalkidan Bishu
J. Wells Askew
Kyle W. Klarich
Jae K. Oh
Paul R. Julsrud
Thomas A. Foley
James F. Glockner
Rick A. Nishimura
Steve R. Ommen
Nandan S. Anavekar
Publication date
01-03-2014
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 3/2014
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-013-0355-y

Other articles of this Issue 3/2014

The International Journal of Cardiovascular Imaging 3/2014 Go to the issue